Last reviewed · How we verify
NNC0385-0434
At a glance
| Generic name | NNC0385-0434 |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease (PHASE2)
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II (PHASE1)
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants (PHASE1)
- A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men (PHASE1)
- A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function (PHASE1)
- A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants (PHASE1)
- A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |